>
Switch to:

Allergy Therapeutics Effective Interest Rate on Debt %

: 4.39% (As of Jun. 2021)
View and export this data going back to 2004. Start your Free Trial

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Allergy Therapeutics's annualized positive value of Interest Expense for the quarter that ended in Jun. 2021 was $0.7 Mil. Allergy Therapeutics's average total debt for the quarter that ended in Jun. 2021 was $15.9 Mil. Therefore, Allergy Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2021 was 4.39%.


Allergy Therapeutics Effective Interest Rate on Debt % Historical Data

The historical data trend for Allergy Therapeutics's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Effective Interest Rate on Debt %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.37 10.22 7.12 6.88 4.46

Allergy Therapeutics Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Effective Interest Rate on Debt % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.94 8.74 3.60 4.15 4.39

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Allergy Therapeutics's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Allergy Therapeutics Effective Interest Rate on Debt % Distribution

For the Drug Manufacturers industry and Healthcare sector, Allergy Therapeutics's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Allergy Therapeutics's Effective Interest Rate on Debt % falls into.



Allergy Therapeutics Effective Interest Rate on Debt % Calculation

Allergy Therapeutics's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Jun. 2021 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Jun. 2020 )+Total Debt  (A: Jun. 2021 ))/ count )
=-1  *  -0.68863955119215/( (15.24280350438+15.669004207574)/ 2 )
=-1  *  -0.68863955119215/15.455903855977
=4.46 %

where

Total Debt  (A: Jun. 2020 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=12.409261576971 + 2.8335419274093
=15.24280350438

Total Debt  (A: Jun. 2021 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=13.207573632539 + 2.4614305750351
=15.669004207574

Allergy Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2021 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2020 )+Total Debt  (Q: Jun. 2021 ))/ count )
=-1  *  -0.6984572230014/( (16.118279569892+15.669004207574)/ 2 )
=-1  *  -0.6984572230014/15.893641888733
=4.39 %

where

Total Debt  (Q: Dec. 2020 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=13.161290322581 + 2.9569892473118
=16.118279569892

Total Debt  (Q: Jun. 2021 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=13.207573632539 + 2.4614305750351
=15.669004207574

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Jun. 2021) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Allergy Therapeutics  (OTCPK:AGYTF) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Allergy Therapeutics Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergy Therapeutics Business Description

Allergy Therapeutics logo
Industry
Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)